Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 1.50B P/E - EPS this Y 27.50% Ern Qtrly Grth -
Income -227.41M Forward P/E -33.77 EPS next Y 73.20% 50D Avg Chg 15.00%
Sales 81.69M PEG 0.04 EPS past 5Y - 200D Avg Chg 53.00%
Dividend N/A Price/Book 8.36 EPS next 5Y -252.60% 52W High Chg -1.00%
Recommedations 2.60 Quick Ratio 3.35 Shares Outstanding 56.23M 52W Low Chg 142.00%
Insider Own 0.68% ROA -24.81% Shares Float 48.51M Beta 0.90
Inst Own 110.60% ROE -82.90% Shares Shorted/Prior 8.99M/6.16M Price 26.68
Gross Margin -80.55% Profit Margin -278.39% Avg. Volume 3,098,164 Target Price 38.00
Oper. Margin -272.02% Earnings Date Aug 3 Volume 11,252,392 Change 0.00%
About Zogenix, Inc.

Zogenix, Inc., a biopharmaceutical company, develops and commercializes therapies to transform the lives of patients and their families living with rare diseases in the United States. The company's lead product candidate is the Fintepla, a low-dose fenfluramine, which is in Phase III clinical trials for the treatment of seizures associated with Dravet syndrome, as well as to treat seizures associated with Lennox-Gastaut syndrome; and that is in Phase II clinical trials for the treatment of other rare epileptic syndromes and diseases. It is also developing MT1621, an investigational therapy for the treatment of a rare genetic disorder called thymidine kinase 2 deficiency. Zogenix, Inc. has a collaboration with Tevard Biosciences for the research, development and commercialization of novel gene therapies for Dravet Syndrome and other genetic epilepsies. The company was formerly known as SJ2 Therapeutics, Inc. and changed its name to Zogenix, Inc. in August 2006. Zogenix, Inc. was incorporated in 2006 and is headquartered in Emeryville, California.

ZGNX Chatroom

User Image New20bie Posted - 03/26/24

$INO approval of any drug will push the MC to 1-5B range. Which is approximately 3x-15x multiple ($38-$190). For comparison check $ZGNX or $CPRX with approved drugs

User Image AlexLevin Posted - 09/25/23

@sogenerous if there are news you will not have time to re-enter (if this is the sort of news we all expect here), you might regret it. Came through that with $ZGNX and $GBT already.

User Image outkastisbackintown Posted - 9 months ago

$ZGNX I can tell you the stock price it s 26 the same price it’s been for 2 years almost no matter what What’s up with that?!?

User Image Quantisnow Posted - 05/31/23

$ZGNX ⚕️ FDA Approval for FINTEPLA issued to ZOGENIX INC https://quantisnow.com/i/4582726?utm_source=stocktwits 45 seconds delayed.

User Image MonopolyTradez Posted - 05/27/23

$ZGNX pt updates

User Image risenhoover Posted - 03/26/23

$ZGNX ZGNX / Zogenix, Inc. Price Target Updated https://fintel.io/sfo/us/zgnx?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 03/25/23

$ZGNX ZGNX / Zogenix, Inc. Price Target Updated https://fintel.io/sfo/us/zgnx?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 03/24/23

$ZGNX ZGNX / Zogenix, Inc. Price Target Updated https://fintel.io/sfo/us/zgnx?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 03/23/23

$ZGNX ZGNX / Zogenix, Inc. Price Target Updated https://fintel.io/sfo/us/zgnx?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 03/22/23

$ZGNX ZGNX / Zogenix, Inc. Price Target Updated https://fintel.io/sfo/us/zgnx?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 03/20/23

$ZGNX ZGNX / Zogenix, Inc. Price Target Updated https://fintel.io/sfo/us/zgnx?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 03/19/23

$ZGNX ZGNX / Zogenix, Inc. Price Target Updated https://fintel.io/sfo/us/zgnx?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 03/18/23

$ZGNX ZGNX / Zogenix, Inc. Price Target Updated https://fintel.io/sfo/us/zgnx?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 03/17/23

$ZGNX ZGNX / Zogenix, Inc. Price Target Updated https://fintel.io/sfo/us/zgnx?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 03/15/23

$ZGNX ZGNX / Zogenix, Inc. Price Target Updated https://fintel.io/sfo/us/zgnx?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 03/14/23

$ZGNX ZGNX / Zogenix, Inc. Price Target Updated https://fintel.io/sfo/us/zgnx?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 03/13/23

$ZGNX ZGNX / Zogenix, Inc. Price Target Updated https://fintel.io/sfo/us/zgnx

User Image Newsfilter Posted - 1 year ago

$ZGNX Approval of Fintepla, Nda #212102 https://newsfilter.io/a/a8d34df028711b3579adb3dfd7e9d8bb

User Image Quantisnow Posted - 1 year ago

$ZGNX ⚕️ FDA Approval for FINTEPLA issued to ZOGENIX INC https://quantisnow.com/i/3869949?utm_source=stocktwits Get the next market-moving insight 45 seconds early at ➡️ https://quantisnow.com/feed ⬅️

User Image Pika_Capital Posted - 12/14/22

$HZNP $HALO $MYOV $GBT $ZGNX Damn just came across this post. 5 out of 7 got acquired since then

User Image BobbyBo69 Posted - 11/14/22

$OPNT They gave the company away. Crazy, when you think about it. It didn't make Roger Crystal a billionaire. In fact, he didn't make much money at all on this, when all things are considered. I don't understand how they give a blockbuster drug in 003 and a company like this away. The 2 other drugs in the pipeline have potential as well. I had such higher hopes but I am taking my money and finding the next one. I will keep 100-150 shares here just to see what happens. This is the second buyout I've been in for 22'. This and $ZGNX. Gotta LOVE bio for this reason. If I see something I love, I will try to let you guys know. Good luck to you all! Good people in this room! If anyone has any ideas for other under the radar stocks shoot them my way. I figured I'd be holding this way longer! ✌🏻

User Image macroaxis Posted - 10/30/22

$ZGNX - Puts open interest is shifting for Zogenix this week https://www.macroaxis.com/stock-options/ZGNX/Zogenix?utm_source=dlvr.it&utm_medium=stocktwits

User Image Newsfilter Posted - 09/29/22

$ZGNX Fenfluramine for Adult Dravet Patients - NCT05560282 https://newsfilter.io/a/80dd99cb05dd7d45a4f6c6b1344dc835

User Image bigwhalealert Posted - 08/22/22

$ZGNX BUY/SELL METER Alert Cross 6% + 🚀 https://t8sk.com/ZGNX

User Image PoorManRising Posted - 08/15/22

@Boilermaker1971 @Bat_Masterson @amiral Companies are being bought out after approvals right now; $ZGNX and $CCXI were two that I benefitted from and there have been several others. Spectrum will still be cheap after the FDA decision and likely with an approved drug. Nobody is going to take a risk on a company without something on the shelf in the tightening environment.

User Image bigwhalealert Posted - 07/21/22

$ZGNX BUY/SELL METER Signal Cross 6% + 🚀 https://t8sk.com/ZGNX

User Image bigwhalealert Posted - 07/13/22

$ZGNX BUY/SELL METER Signal Cross 6% + 🚀 https://t8sk.com/ZGNX

User Image Newsfilter Posted - 06/16/22

$ZGNX Approval of Fintepla, Nda #212102 https://newsfilter.io/a/a8d34df028711b3579adb3dfd7e9d8bb

User Image Quantisnow Posted - 06/16/22

$ZGNX ⚕️ FDA Approval for FINTEPLA issued to ZOGENIX INC https://quantisnow.com/i/3035405?utm_source=stocktwits 45 seconds delayed.

User Image cctranscripts Posted - 05/16/22

RA Capital Healthcare Fund, L.P. just issued a filing suggesting it has sold all of its Zogenix https://www.conferencecalltranscripts.com/summary/?id=10857266 $ZGNX

Analyst Ratings
Needham Hold Jan 19, 22
SVB Leerink Outperform Dec 20, 21
UBS Buy Sep 9, 21
Needham Buy Aug 6, 21
SVB Leerink Outperform Aug 6, 21
Raymond James Market Perform Aug 25, 20
Needham Buy Jun 29, 20
Needham Buy May 6, 20
Mizuho Buy Apr 1, 20
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
MAST ERLE T Director Director Jan 19 Option 13.97 15,000 209,550 18,027 01/21/22
MAST ERLE T Director Director Jan 19 Sell 26.09 15,000 391,350 3,027 01/21/22